| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | AGIOS PHARMACEUTICALS, INC. | AGIO | Exercise | Restricted stock units | 2.3k | $0.00 | $0 | | 08/11/2023 |
| 02/22/2023 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 32.9k | $4.66 | $153.1k | | 02/22/2023 |
| 08/11/2022 | AGIOS PHARMACEUTICALS, INC. | AGIO | Grant | Restricted stock units | 6.9k | $0.00 | $0 | | 08/11/2022 |
| 08/11/2022 | AGIOS PHARMACEUTICALS, INC. | AGIO | Grant | Stock option (right to buy) | 37.9k | $25.99 | $986.2k | | 08/11/2022 |
| 01/28/2022 | Enliven Therapeutics, Inc. | IMRA | Grant | Stock Option (right to buy) | 131.4k | $1.38 | $181.3k | | 01/28/2022 |
| 01/28/2022 | Enliven Therapeutics, Inc. | IMRA | Grant | Common Stock | 131.4k | $0.00 | $0 | | 01/28/2022 |
| 01/28/2021 | Enliven Therapeutics, Inc. | IMRA | Grant | Stock Option (right to buy) | 133.4k | $13.05 | $1.7M | | 01/28/2021 |
| 12/17/2020 | Enliven Therapeutics, Inc. | IMRA | Exercise | Stock Option (Right to Buy) | 5k | $3.15 | $15.7k | | 12/17/2020 |
| 12/17/2020 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 5k | $25.00 | $125k | | 12/17/2020 |
| 12/14/2020 | Enliven Therapeutics, Inc. | IMRA | Exercise | Stock Option (Right to Buy) | 1 | $3.15 | $3.2 | | 12/14/2020 |
| 12/14/2020 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 1 | $25.00 | $25 | | 12/14/2020 |